New marker for bowel cancer (colon cancer or rectal cancer)

A new discovery could play an important role in establishing which bowel cancer patients are most likely to require chemotherapy.

The discovery is based around a protein called FOXO3. Scientists have discovered that patients with low levels of the protein have an increased risk of their cancer spreading to other parts of the body. Such patients are deemed ‘most at risk’ and probably require chemotherapy.

Read more:
New marker for bowel cancer

Source: Digital Journal
Image credit: Creative Commons - Attribution-ShareAlike


Art and Science of Laboratory Medicine

Facebook: www.facebook.com/LaboratoryEQAS

Twitter: LaboratoryEQAS

Pinterest: http://pinterest.com/labmed/medical-laboratory-and-biomedical-science/